WHITEHAWK THERAPEUTICS, INC. Current Liabilities
WHITEHAWK THERAPEUTICS, INC. (WHWK) had Current Liabilities of $11.07 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Liabilities, Current $11.07M.
- 2026-03-31: Liabilities, Current $11.06M.
- 2025-12-31: Liabilities, Current $14.52M.
- 2025-09-30: Liabilities, Current $9.85M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $11.07M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $11.06M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $14.52M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $9.85M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $8.76M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $12.27M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $17.07M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $15.81M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $22.15M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $19.88M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $26.39M 10-K · filed 2025-03-28 | |
| 2023-09-30 | $20.52M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $13.00M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $17.75M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $18.84M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $17.89M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $12.60M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $11.51M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $15.27M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $11.57M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $2.21M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $2.13M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $30.06M 10-K · filed 2022-03-17 | $1.87M 10-K · filed 2021-03-11 |
| 2020-09-30 | $2.51M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $3.11M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $2.65M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $3.33M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $3.60M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $3.60M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $3.92M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $5.46M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $3.64M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $21.63M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $3.62M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $3.59M 10-K · filed 2019-03-07 | |
| 2017-09-30 | $2.59M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $1.86M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $2.97M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $14.86M 10-K · filed 2018-03-15 | $229.93K 10-K · filed 2017-03-07 |
| 2016-09-30 | $215.09K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $220.76K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $206.07K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $205.01K 10-K · filed 2017-03-07 | |
| 2015-09-30 | $180.92K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $178.22K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $184.14K 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $160.30K 10-K · filed 2016-03-30 | |
| 2014-09-30 | $161.26K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $141.53K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $136.52K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $133.03K 10-K · filed 2015-02-27 | |
| 2013-09-30 | $129.16K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $126.77K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $105.44K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $103.65K 10-K · filed 2014-03-31 | |
| 2012-09-30 | $97.14K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $95.40K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $97.76K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $74.80K 10-K · filed 2013-03-28 | |
| 2011-09-30 | $69.75K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $68.39K 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $70.39K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |